Seol Min-Ah, Park Jung-Hwan, Jeong Ji Heun, Lyu Jungmook, Han Seung Yun, Oh Sang-Muk
Department of Biochemistry, College of Medicine, Konyang University, Daejeon, Korea.
Department of Anatomy, College of Medicine, Konyang University, Daejeon, Korea.
Oncotarget. 2017 Jun 20;8(25):40190-40203. doi: 10.18632/oncotarget.15360.
Inflammation has been known to be linked to invasion or metastasis of breast cancer, which has poor prognosis, although the regulatory mechanism remains to be undiscovered. Here we show that T-LAK cell-originated protein kinase (TOPK) mediates pro-inflammatory endotoxin lipopolysaccharide (LPS)-induced breast cancer cell migration and invasion. The mRNA or protein level of TOPK, toll- like receptor4 (TLR4), interleukin (IL)-6, vascular endothelial growth factor (VEGF) or matrix metalloproteinase9 (MMP9) genes related to TLR4 signaling or tumor progression was induced by LPS treatment in MCF7 breast cancer cells, but the induction was abolished by stable knocking down of TOPK in MCF7 cells. Also, TOPK depletion decreased LPS-induced phosphorylation of p38, but not ERK and JNK among mitogen-activated protein kinases (MAPKs). On the other hand, we revealed that TOPK is essential for transcriptional activity of NF-κB or MMP9 promoter triggered by LPS. The induced promoter activity of NF-κB or MMP9 but not AP-1 was inhibited by knocking down of TOPK. Furthermore, we demonstrated that inhibitor of TOPK or MMP9 as well as MMP9 siRNA efficiently blocked LPS-induced migration or invasion of breast cancer cell lines. Interestingly, both of expression of TOPK and TLR4 were markedly increased in high-grade breast cancer. Collectively, we conclude that TOPK functions as a key mediator of LPS/TLR4-induced breast cancer cell migration and invasion through regulation of MMP9 expression or activity, implying a potential role of TOPK as a therapeutic target linking LPS-induced inflammation to breast cancer development.
炎症已知与预后较差的乳腺癌侵袭或转移有关,尽管其调控机制仍有待发现。在此我们表明,T淋巴细胞激活杀伤细胞源蛋白激酶(TOPK)介导促炎性内毒素脂多糖(LPS)诱导的乳腺癌细胞迁移和侵袭。在MCF7乳腺癌细胞中,LPS处理可诱导与TLR4信号传导或肿瘤进展相关的TOPK、Toll样受体4(TLR4)、白细胞介素(IL)-6、血管内皮生长因子(VEGF)或基质金属蛋白酶9(MMP9)基因的mRNA或蛋白水平,但在MCF7细胞中稳定敲低TOPK可消除这种诱导作用。此外,TOPK缺失降低了LPS诱导的p38磷酸化,但在丝裂原活化蛋白激酶(MAPK)中未降低ERK和JNK的磷酸化。另一方面,我们发现TOPK对于LPS触发的NF-κB或MMP9启动子的转录活性至关重要。敲低TOPK可抑制NF-κB或MMP9而非AP-1的诱导启动子活性。此外,我们证明TOPK或MMP9抑制剂以及MMP9 siRNA可有效阻断LPS诱导的乳腺癌细胞系迁移或侵袭。有趣的是,在高级别乳腺癌中TOPK和TLR4的表达均显著增加。总体而言,我们得出结论,TOPK通过调节MMP9的表达或活性,作为LPS/TLR4诱导的乳腺癌细胞迁移和侵袭的关键介质,这意味着TOPK作为将LPS诱导的炎症与乳腺癌发展联系起来的治疗靶点具有潜在作用。